HELX
HELX
About Franklin Genomic Advancements ETF
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically,...
About Franklin Genomic Advancements ETF
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically,...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GH | Guardant Health, Inc. | 9.65% | 18.14K | $2.87M |
 NTRA | Natera, Inc. | 7.54% | 8.23K | $2.25M |
 KRYS | Krystal Biotech, Inc. | 6.22% | 5.10K | $1.85M |
 LGND | Ligand Pharmaceuticals Incorporated | 4.55% | 4.38K | $1.35M |
 BBIO | BridgeBio Pharma, Inc. | 3.93% | 14.07K | $1.17M |
 ADPT | Adaptive Biotechnologies Corporation | 3.93% | 55.67K | $1.17M |
 UTHR | United Therapeutics Corporation | 3.49% | 1.94K | $1.04M |
 LLY | Eli Lilly and Company | 2.93% | 737 | $871.04K |
 VRTX | Vertex Pharmaceuticals Incorporated | 2.67% | 1.66K | $794.81K |
 TVTX | Travere Therapeutics, Inc. | 2.58% | 13.66K | $769.09K |
 TWST | Twist Bioscience Corporation | 2.52% | 8.29K | $748.82K |
 INSM | Insmed Incorporated | 2.51% | 6.84K | $746.95K |
 CTVA | Corteva, Inc. | 2.30% | 7.97K | $685.63K |
 MEDP | Medpace Holdings, Inc. | 2.16% | 1.21K | $643.12K |
 REGN | Regeneron Pharmaceuticals, Inc. | 1.92% | 862 | $571.58K |
 NBIX | Neurocrine Biosciences, Inc. | 1.92% | 3.28K | $570.35K |
 TEM | Tempus AI, Inc. | 1.89% | 10.07K | $563.10K |
 ALNY | Alnylam Pharmaceuticals, Inc. | 1.88% | 1.95K | $560.28K |
 VCYT | Veracyte, Inc. | 1.62% | 8.38K | $481.51K |
 PTCT | PTC Therapeutics, Inc. | 1.47% | 5.37K | $436.42K |
SECTOR HOLDINGS
Healthcare
Basic Materials
TechnologyASSET ALLOCATION BY REGION
United States
United Kingdom
South Korea
Germany
Netherlands
Switzerland
Ireland
SingaporeSECTOR HOLDINGS
Healthcare Basic Materials TechnologyASSET ALLOCATION BY REGION
United States United Kingdom South Korea Germany Netherlands Switzerland Ireland SingaporeHoldings (Top 20)
GH
Guardant Health, Inc.
NTRA
Natera, Inc.
KRYS
Krystal Biotech, Inc.
LGND
Ligand Pharmaceuticals Incorporated
BBIO
BridgeBio Pharma, Inc.
ADPT
Adaptive Biotechnologies Corporation
UTHR
United Therapeutics Corporation
LLY
Eli Lilly and Company
VRTX
Vertex Pharmaceuticals Incorporated
TVTX
Travere Therapeutics, Inc.
TWST
Twist Bioscience Corporation
INSM
Insmed Incorporated
CTVA
Corteva, Inc.
MEDP
Medpace Holdings, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
NBIX
Neurocrine Biosciences, Inc.
TEM
Tempus AI, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
VCYT
Veracyte, Inc.
PTCT
PTC Therapeutics, Inc.